Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
|
|
Audience:
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from
Merck Sharp & Dohme LLC
Description:
Heart failure (HF) is a common condition that affects approximately
5.7 million people in the United States, and the prognosis for
patients with heart failure has traditionally been poor. Projections
show that by 2030, the prevalence of heart failure will increase 46
percent from recent estimates. HF is the reason for more than 1
million hospitalizations per year and an estimated $31 billion in
costs in the U.S. each year. While recent efforts have focused on
improving the outlook for patients with chronic heart failure,
mortality and morbidity following admission for heart failure remain
significant. Fortunately for patients with HF, new and emerging
therapeutic options have entered the treatment paradigm recently,
including SGLT2 inhibitors, showing the ability to improve clinical
and economic outcomes for the patient and system, which makes it
imperative to update medical directors, practicing physicians,
nurses and other healthcare professionals on recent clinical data
and recommendation updates regarding these new therapy options.
Upon completion of this
activity, participants will be able to:
-
Describe the phenotypes of HF in
terms of epidemiology, disease burden, diagnosis, and treatment
approaches
-
Explore the differences between
heart failure with preserved or reduced ejection fraction (HFpEF
or HFrEF)
-
Evaluate the efficacy and safety
data and mechanisms of action of newer therapies, including sGC
stimulators and SGLT2 inhibitors, indicated for the management
of HFrEF and associated clinical implications, including WHF and
hospitalization frequency
-
Identify patients at high risk for
worsening heart failure to prevent life-threatening events
through prompt intervention
-
Assess strategies to improve the
provision of guideline-directed care in clinical practice for
optimal HF treatment and patient outcomes
-
Implement evidence-based,
patient-centric, and cost-effective managed care strategies to
reduce the burden of HF
Faculty:
Alanna Morris MD, MSc, FHFSA, FACC, FAHA
Associate Professor of Medicine, Division of Cardiology
Director of Heart Failure Research
Emory University Clinical Cardiovascular Research Institute
Disclosure Information:
As accredited providers, NAMCP and AAMCN must ensure balance,
independence, objectivity, and scientific rigor in all of their
activities. All faculty participating in this activity are required
to disclose to NAMCP/AAMCN any financial relationships with
ineligible companies. NAMCP/AAMCN in turn discloses all relevant
financial conflicts to the learners. NAMCP/AAMCN disclosure policy
adheres to The Standards for Integrity and Independence in
Accredited Continuing Education. All relevant conflicts of interest
have been mitigated prior to the commencement of the activity. See
below for conflicts of interest.
Disclosures (Relevant Financial Relationships with Ineligible
Companies in the Last 24 Months):
Dr. Morris has served as a consultant for Abbott Laboratories,
Acorai, BI/Lilly, Cytokinetics, Edwards Lifesciences, Ionis, Merck,
and Regeneron. All relevant conflicts of interest have been
mitigated.
Planning Committee Disclosures (Relevant Financial Relationships
with Ineligible Companies in the Last 24 Months):
Bill Williams, MD has no relevant financial relationship with an
ineligible company to disclose.
Jeremy Williams has no relevant financial relationship with an
ineligible company to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationship
with an ineligible company to disclose.
NAMCP and/or the presenter has copyright or has received permissions
for use of materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring
material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
NAMCP and/or this website do not provide medical advice, diagnosis,
or treatment. NAMCP does not endorse or imply endorsement of the
content on any linked website. This website is to be used as an
informational resource. With any health-related concern, consult
with your physician or healthcare professional.
This activity is supported by an educational grant from
Merck Sharp & Dohme LLC
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
professional.
Click Here To Continue |